What is it?
What the memory trials can tell you
3A Japanese soy-PS trial reported selected memory findings after repeated use, but overall test scores also improved with placebo. Findings from older adults with memory complaints do not establish a universal productivity benefit.
Names, aliases and forms
Mechanisms of action
Membrane phospholipid biology
1Phosphatidylserine is part of cell membranes and participates in membrane signaling. That mechanism supports why it is studied for cognition, but mechanism alone is not evidence that every supplement form improves memory.
Stress-hormone studies are not calm claims
6A ten-person trial measured cortisol around exercise after ten days of soy-PS use. A hormone measurement in that setting does not establish improved everyday stress, sleep, or mood.
Potential effects and evidence map
Grade C: small human studies report selective memory findings, while a 120-person soy-PS trial found no cognitive benefit. Population, formulation, and subgroup analyses limit confidence; PS combined with omega-3 is not equivalent evidence for every PS product.
Memory findings in older adults with complaints are mixed: selected positive results coexist with a null soy-PS trial.
A small repeated-use study measured a lower cortisol response around exercise; everyday stress relief was not established.
Available clinical studies do not establish a dependable focus benefit for generally healthy young adults.
The cited memory trials do not establish same-day wakefulness or an acute energy effect.
Typical dosages and timing
These were the two PS amounts in the six-month Japanese memory trial, not a personalized dosing recommendation. A separate 12-week trial tested higher intakes without cognitive benefit. Count the PS itself, not total phospholipid complex or capsule fill.
Timing & effect horizon
The featured six-month window belongs to the Japanese soy-PS trial. Other memory studies lasted 12 or 15 weeks. These schedules do not define how quickly an individual should notice effects, how long an effect lasts, or an evidence-based cycling schedule.
Safety, side effects and risk profile
The cited trials do not establish safety for combining PS with medicines or complex supplement stacks.
Supplemental-use safety during pregnancy and breastfeeding is insufficiently established.
Trials lasting weeks to months cannot establish rare-event or indefinite-use safety for every formulation.
As of October 2026, U.S. GRAS Notice 636 is recorded as evaluation ceased at the notifier's request.
Interactions and cautions
The PS safety trials do not establish compatibility with every medicine or multi-ingredient blend. A product containing other active ingredients needs an assessment of those ingredients too. No specific drug interaction is established by the sources cited here.
Legal and regulatory status
As of October 13, 2026, the FDA record for sunflower-derived PS GRAS Notice 636 states that evaluation ceased at the notifier's request. It should not be described as an FDA no-questions response or approval of memory benefits. Requirements differ by source, intended use, product category, and jurisdiction.
How it compares
The PS-omega-3 memory trial used a particular preparation with omega-3 fatty acids attached to PS. Its result cannot establish that plain soy or sunflower PS, or a separately assembled fish-oil stack, performs the same way. Match the studied preparation and population before comparing claims.
Practical buying and quality notes
- If a label states that a 500 mg complex supplies 100 mg PS, count it as 100 mg PS. Divide package price by the number of servings at the same actual PS amount. Powder weight and capsule count alone cannot make different concentrations comparable. Confirm retailer quantities when a catalog row shows zero or conflicting values.3
- Check whether the label specifies soy, sunflower, or a PS-omega-3 preparation, and whether it lists PS amount separately from total lipid weight. Review the full ingredient and allergen declaration and batch identity/purity documentation. A source change does not itself prove equal clinical effects.5
FAQ
Does a higher dose mean a better result?
4No dose-response advantage is established. The 120-person soy-PS trial compared 300 and 600 mg per day with placebo over 12 weeks and found no cognitive treatment effect. More milligrams or a larger complex on the label does not demonstrate better memory outcomes.
Is a 500 mg PS complex the same as 500 mg PS?
3Only when the label explicitly declares that amount of phosphatidylserine. A complex includes other material, so use the stated PS yield to calculate comparable servings. If the actual PS amount is missing, a reliable PS-normalized price cannot be calculated.
References
- PubChem Compound Summary for CID 9547096, Phosphatidylserine.
- U.S. Food and Drug Administration. GRAS Notice 636: phosphatidylserine derived from sunflower lecithin.
- Kato-Kataoka A, Sakai M, Ebina R, et al. Soybean-derived phosphatidylserine and memory function in older adults with memory complaints. J Clin Biochem Nutr. 2010.
- Jorissen BL, Brouns F, Van Boxtel MP, et al. Soy-derived phosphatidylserine and cognition in age-associated memory impairment. Nutr Neurosci. 2001.
- Vakhapova V, Cohen T, Richter Y, et al. Phosphatidylserine with omega-3 fatty acids and memory in older adults with memory complaints. Dement Geriatr Cogn Disord. 2010.
- Starks MA, Starks SL, Kingsley M, et al. Phosphatidylserine and endocrine response to moderate-intensity exercise. J Int Soc Sports Nutr. 2008.
- Jorissen BL, Brouns F, Van Boxtel MP, et al. Safety of soy-derived phosphatidylserine in elderly people. Nutr Neurosci. 2002.
- Health Canada. Summary of safety assessment of phosphatidylserine for use as a supplemental ingredient.
- Health Canada. Modification to permit phosphatidylserine (soy) as a supplemental ingredient.
- Gundogan Kucuksahin N, et al. Citicoline/phosphatidylserine supplementation and cognitive performance in mental disorders: systematic review of controlled trials. Human Psychopharmacology. 2026.